Litigation Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. EMCURE PHARMACEUTICALS LTD (D.N.J. 2018)
✉ Email this page to a colleague
SUMITOMO DAINIPPON PHARMA CO., LTD. v. EMCURE PHARMACEUTICALS LTD (D.N.J. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-02-12 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-11-26 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | Referred To | Cathy L. Waldor | |
| Patents | 7,323,493; 8,729,085; 8,883,794; 9,555,027; 9,815,827; 9,907,794 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUMITOMO DAINIPPON PHARMA CO., LTD. v. EMCURE PHARMACEUTICALS LTD
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. EMCURE PHARMACEUTICALS LTD (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-10-05 | 131 | Opinion | application, which issued as U.S. Patent No. 7,323,493, Sanofi amended the sole independent claims…intrinsic to the patent (the patent claims and specifications, along with the patent’s prosecution history…terms in the ‘827 patent and a single term in the ‘794 patent. At issue in the ‘827 patent is the meaning…in Non-patent Document 1.” ‘085 patent, col.2 ll.9-13. The specification identifies Non-patent Document…consolidated patent infringement actions, the parties seek construction of claim terms in U.S. Patent No. 9, | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
